For the Inventor, By the Inventor

Enter assignee name

Hopkinton, MA, United States of America

Creative Biomolecules, Inc.

USPTO Granted Patents = 72

CIPO Patents = 1

Forward Citations = 3,528

Loading Chart...

Loading Chart...

48 inventors (with patents filed for the assignee):

Hermann Oppermann (41 out of 88 patents)

Charles M Cohen (29 out of 60 patents)

David C Rueger (22 out of 83 patents)

4. Thangavel Kuberasampath (22 out of 67 patents)

5. Roy H Pang (20 out of 26 patents)

6. James S Huston (17 out of 25 patents)

7. Engin Ozkaynak (12 out of 46 patents)

8. Kuber T Sampath (11 out of 46 patents)

9. John E Smart (10 out of 19 patents)

10. Peter C Keck (8 out of 18 patents)

11. Marc F Charette (7 out of 13 patents)

12. Roberto Crea (6 out of 10 patents)

13. Haimanti Dorai (6 out of 6 patents)

14. Richard J Ridge (5 out of 8 patents)

15. David B Ring (3 out of 33 patents)

Core Competencies:

Morphogen Analog

Inflammatory Response

Tissue Regeneration

Protein Production

Biosynthetic Binding Proteins

Osteogenic Devices

Platelet Derived Growth Factor

Gene Design

Synthetic Bioadhesive

Cell Surface Receptor

Gastrointestinal Ulcers

Morphogenic Protein

72 patents: Sort by Forward Citations

1. 6273598 - Computer system and methods for producing morphogen analogs of human OP-1 (2001-08-14),

2. 6194376 - Method for modulating inflammatory response comprising administering morphogen (2001-02-27),

3. 6110460 - Methods of using morphogen analogs (2000-08-29),

4. 6103491 - Methods and compositions for identifying morphogen analogs (2000-08-15),

5. 6093547 - Morphogen cell surface receptor and screening for morphogen analogs (2000-07-25),

6. 6090776 - Morphogen treatment of organ implants (2000-07-18),

7. 6090544 - Methods and compositions for identifying morphogen analogs (2000-07-18),

8. 6077823 - Method for reducing tissue damage associated with ischemia-reperfusion (2000-06-20),

9. 6071695 - Methods and products for identification of modulators of osteogenic (2000-06-06),

10. 6022853 - Morphogen-enriched dietary composition (2000-02-08),

11. 5994131 - Morphogenic protein screening method (1999-11-30),

12. 5972884 - Morphogen treatment of gastrointestinal ulcers (1999-10-26),

13. 5968752 - Method for identifying an OP-1 analog which binds an ALK-1 receptor (1999-10-19),

14. 5932716 - Morphogen-responsive regulatory elements (1999-08-03),

15. 5928940 - Morphogen-responsive signal transducer and methods of use thereof (1999-07-27),

Company Overview

Creative Biomolecules, Inc., located in Hopkinton, MA, specializes in morphogen technology, focusing on innovative solutions for tissue regeneration and inflammatory response management. The company develops a range of products including morphogen analogs, biosynthetic binding proteins, and osteogenic devices, leveraging advanced protein production techniques. Their research encompasses gene design and the application of platelet-derived growth factors, aiming to enhance therapeutic outcomes in regenerative medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

72 Patents

#3 in Hopkinton, MA

#282 in Massachusetts

#5,101 in US

#10,383 in the World

Hopkinton, MA, United States of America

Creative Biomolecules, Inc.

Forward Citations = 3,528

48 inventors:

Hermann Oppermann (41 out of 88 patents)

Charles M Cohen (29 out of 60 patents)

David C Rueger (22 out of 83 patents)

4. Thangavel Kuberasampath (22 out of 67 patents)

5. Roy H Pang (20 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Creative Biomolecules, Inc.. Retrieved from https://idiyas.com/company/creative-biomolecules

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…